- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 3.61M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.24M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 2.33M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$13.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$12.99M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $15.17M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $25.98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $26.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $34.94M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $55.86M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $65.47M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.89M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.57M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.26M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $15.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $31.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $43.75M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $37.98M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $50.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.87 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$4.70 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.87 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$4.70 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.27M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.73M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.83M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $7.9M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$9.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$10.98M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.11M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$11.62M |